outcomeCategory,disease,model,comparison,database,nTNF,nComparator,HazardRatio,RobustWaldLower,RobustWaldUpper,indValidHR,indSigHR
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,526,125,51447.545869,12658.062075,209103.88655,0,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2061,707,0.2646854695,0.0662799451,1.057007481,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2271,1423,0.7795271577,0.4370395189,1.390406504,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,1.1621846456,0.1634177456,8.2651559408,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2061,2612,0.9073595232,0.244197225,3.3714605248,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2271,4212,1.2404035974,0.7702123601,1.997632295,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,526,125,43721.2109,9796.9323345,195116.61582,0,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2061,707,0.1355165383,0.03149154,0.5831639901,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,2271,1423,0.9465327912,0.4816048714,1.8602891667,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,0.9078818754,0.1175684671,7.0108041736,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2061,2612,0.4550047118,0.1088821669,1.9014067555,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2271,4212,1.5254810564,0.849222589,2.7402620745,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,526,125,35446.398375,7918.642306,158669.51798,0,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2061,707,0.1363388159,0.0317515581,0.5854286793,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2271,1423,0.9179704967,0.4704642937,1.791145139,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,526,631,0.9284973259,0.1200600068,7.1806366416,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2061,2612,0.4542048321,0.1087246742,1.897472042,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2271,4212,1.5409489463,0.8554939478,2.7756171287,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,526,125,44084.531778,9858.8977316,197126.08803,0,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2061,707,0.1247820671,0.0289163153,0.5384698612,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2271,1423,0.8906100456,0.4557599582,1.7403596762,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,526,631,0.8930547352,0.1157177091,6.8921755023,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2061,2612,0.4564855614,0.1093101978,1.9063094925,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2271,4212,1.5535496795,0.8641790202,2.7928433233,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,526,125,43469.070407,9734.8627892,194102.38469,0,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2061,707,0.1359749515,0.0316000677,0.5850996152,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2271,1423,0.9414418845,0.4799477924,1.8466859017,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,526,631,0.9095112222,0.117776404,7.0235686871,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2061,2612,0.4517851297,0.1079391235,1.8909714738,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2271,4212,1.5366543148,0.8547845252,2.7624581557,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,526,125,57699.832398,12847.452141,259138.592,0,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2061,707,0.1274856758,0.029677214,0.547645662,1,1
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2271,1423,0.8568082318,0.4425158896,1.6589694593,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,526,631,0.9117756193,0.1181000682,7.0392404714,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2061,2612,0.4498418098,0.1074833656,1.8826881048,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2271,4212,1.5729899518,0.8718800268,2.8378874528,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,526,125,27397.065907,8668.7731933,86586.556547,0,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2065,708,0.4748098232,0.226384982,0.9958450701,1,1
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2271,1423,0.7657222016,0.5420999429,1.0815911304,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,0.859227688,0.1934541954,3.816263682,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2065,2615,1.6123159538,0.809364971,3.2118547603,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2271,4212,1.1145714212,0.8534778088,1.4555380822,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,526,125,20754.271692,5984.6124503,71974.550908,0,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2065,708,0.4554484212,0.2011563349,1.0312042349,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,2271,1423,1.0029903103,0.6844547807,1.4697677494,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,0.6995813129,0.1454276015,3.3653447378,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2065,2615,1.9660118642,0.9124775211,4.2359428706,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2271,4212,1.5350256973,1.1238678123,2.0966023455,1,1
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,526,125,20625.58405,5937.9114141,71643.830251,0,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2065,708,0.4517207045,0.1991948562,1.0243818478,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2271,1423,1.0096077643,0.6888424766,1.4797401035,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,526,631,0.7049861511,0.1463026648,3.3971047201,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2065,2615,1.9553165956,0.9070525881,4.2150400529,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2271,4212,1.5330903505,1.1227397288,2.0934201958,1,1
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,526,125,20914.832236,6013.7409447,72738.452072,0,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2065,708,0.4124936071,0.182246806,0.9336293985,1,1
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2271,1423,0.9327990352,0.6401198075,1.3592987279,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,526,631,0.6864034936,0.1424219514,3.3081259689,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2065,2615,1.9741960524,0.9167360746,4.2514417848,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2271,4212,1.5781645088,1.1535877565,2.1590062851,1,1
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,526,125,20708.092651,5970.6246445,71822.485383,0,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2065,708,0.4560713105,0.2014681906,1.0324262093,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2271,1423,1.0021216628,0.6840322197,1.4681294214,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,526,631,0.6999051594,0.1454960331,3.3668768953,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2065,2615,1.9628152161,0.9107708088,4.230091188,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2271,4212,1.5385419101,1.1266911711,2.1009405859,1,1
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,526,125,20693.645564,5935.9814922,72140.88644,0,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2065,708,0.4052313333,0.1788344555,0.9182371095,1,1
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2271,1423,0.9405050234,0.6449389569,1.3715246838,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,526,631,0.685918085,0.1421532212,3.3096936919,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2065,2615,1.9561725974,0.9072985794,4.2175875918,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2271,4212,1.5774068257,1.1531597391,2.1577342751,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,521,125,0.7165776238,0.2364581311,2.1715619953,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2043,700,0.5226433696,0.3170485477,0.8615591957,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2248,1388,0.6530061733,0.5171266375,0.8245892426,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,521,625,1.333989726,0.6178194163,2.8803377526,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2043,2605,1.1563782981,0.7706142267,1.7352531551,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2248,4162,1.0167306005,0.8392067032,1.2318075034,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,521,125,0.4824757592,0.1349224992,1.7253079329,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2043,700,0.6688521333,0.3821614513,1.1706130345,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,2248,1388,0.7759671707,0.5921726811,1.0168065317,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,521,625,1.297897764,0.5752205598,2.9285090338,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2043,2605,1.5696579604,0.9758425495,2.5248193103,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2248,4162,1.2438869945,0.981964533,1.5756728508,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,521,125,0.4872375702,0.1362647473,1.7422000525,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2043,700,0.6670959498,0.3808120846,1.1686000108,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2248,1388,0.7729292408,0.5902470772,1.0121517486,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,521,625,1.2983637012,0.5754516046,2.9294353985,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2043,2605,1.5729105605,0.9778715679,2.5300333014,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2248,4162,1.2452874019,0.9815502683,1.579889246,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,521,125,0.4828267455,0.1344648274,1.7336999622,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2043,700,0.644764041,0.3693630519,1.1255069137,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2248,1388,0.7524410864,0.5716716655,0.9903719613,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,521,625,1.2895106776,0.5710094007,2.9121022976,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2043,2605,1.5756292719,0.9798069762,2.533772123,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2248,4162,1.2547416809,0.9917256014,1.5875123963,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,521,125,0.4817831714,0.1347187701,1.7229597936,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2043,700,0.6696406363,0.3825615473,1.1721475539,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2248,1388,0.7751540537,0.5905399583,1.0174820494,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,521,625,1.2982719487,0.5753861194,2.9293547339,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2043,2605,1.5684076167,0.9750511375,2.522844554,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2248,4162,1.2442918297,0.9829463581,1.5751237538,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,521,125,0.487381546,0.1357387773,1.7499846101,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2043,700,0.645050442,0.3690794294,1.1273726998,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2248,1388,0.7491994198,0.5679026032,0.9883733012,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,521,625,1.2905305558,0.5715011461,2.9142008317,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2043,2605,1.5780331729,0.9812361441,2.5378077539,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2248,4162,1.255946982,0.9910464386,1.5916537917,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,526,125,56055.01492,27156.833611,115704.38375,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2055,708,0.6648995767,0.2781218829,1.5895600969,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2263,1411,1.0731338088,0.7814910317,1.4736140593,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,2.2873788874,0.6882156696,7.6024165182,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2055,2607,1.8140437734,0.8565737939,3.8417645219,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2263,4195,1.336283183,1.0502773961,1.700172499,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,MPCD,526,125,76848.268637,33161.964536,178085.23937,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2055,708,0.6134997284,0.2219182486,1.6960386049,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Medicare,2263,1411,1.6056732663,1.0489656101,2.4578371431,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,3.7047665055,1.0190797236,13.468322981,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2055,2607,1.9502960028,0.8563773619,4.4415635766,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2263,4195,2.152461951,1.4728780358,3.145604957,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,526,125,77836.094647,33503.498949,180830.59441,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2055,708,0.6087122568,0.2199939115,1.6842766655,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2263,1411,1.6044547793,1.0531796213,2.4442887869,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,526,631,3.7286671849,1.0254345919,13.558113882,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2055,2607,1.9515865184,0.8568785622,4.4448421358,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2263,4195,2.1526718709,1.4668913698,3.1590588638,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,526,125,76884.815353,33159.490491,178267.96324,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2055,708,0.631898366,0.2277506097,1.7532139457,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2263,1411,1.6460202688,1.0435129633,2.5964054311,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,526,631,3.7292292599,1.0251535593,13.565919707,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2055,2607,1.9459441101,0.8542786842,4.4326266706,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2263,4195,2.1378329665,1.4771785233,3.0939590039,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,526,125,78199.108817,33746.273311,181208.1756,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2055,708,0.6113243318,0.2210246028,1.6908409016,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2263,1411,1.6086551908,1.051018091,2.4621569745,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,526,631,3.6984460901,1.0172254257,13.446875329,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2055,2607,1.9610648591,0.8611644776,4.4657849708,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2263,4195,2.1369916013,1.4716124023,3.103217326,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,526,125,79311.156735,34124.402201,184333.18027,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2055,708,0.6232370141,0.2242349619,1.7322204012,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2263,1411,1.6417960329,1.0531496446,2.559459833,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,526,631,3.7415510031,1.0280766377,13.616887492,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2055,2607,1.9561977342,0.8589228252,4.4552426167,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2263,4195,2.1235753875,1.4725432563,3.062438001,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,526,125,23714.426522,7526.5892019,74718.310003,0,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2063,707,1.0125693702,0.3387902305,3.0263467984,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2262,1414,0.8708146074,0.6249528645,1.2134004394,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,1.7112714807,0.2863747519,10.225936683,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2063,2611,0.7230591322,0.384981637,1.3580245353,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2262,4195,1.0861902655,0.8398701291,1.4047520586,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,MPCD,526,125,29112.524852,8164.7301801,103804.91267,0,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2063,707,1.5969027847,0.5161391387,4.9407191059,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Medicare,2262,1414,0.9843837662,0.6816864608,1.4214913378,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,2.0119194628,0.3093077853,13.086705596,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2063,2611,1.1074985292,0.5546268545,2.2114922531,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2262,4195,1.3089018847,0.9658373362,1.7738226507,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,526,125,29197.337232,8181.5039662,104196.55175,0,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2063,707,1.6094405558,0.5197844123,4.9834101242,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2262,1414,0.9821522604,0.6805416938,1.4174341873,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,526,631,2.0043648473,0.3082009717,13.035255598,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2063,2611,1.1079799226,0.5548883704,2.2123720272,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2262,4195,1.3120777362,0.9671645965,1.7799948344,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,526,125,29161.415746,8150.2946309,104338.3346,0,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2063,707,1.5245805547,0.4917858189,4.7263377239,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2262,1414,0.9526671269,0.6577764367,1.3797615786,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,526,631,1.991451081,0.3055443262,12.979712166,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2063,2611,1.1105627411,0.5563326397,2.2169283516,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2262,4195,1.3259809752,0.9793933021,1.7952190839,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,526,125,29212.750489,8192.3739159,104168.19348,0,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2063,707,1.5943760153,0.5152695247,4.9334081612,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2262,1414,0.9854809624,0.6822164314,1.423555169,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,526,631,2.0107827619,0.309125477,13.079631467,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2063,2611,1.1096004228,0.5557390094,2.2154519971,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2262,4195,1.3053226784,0.9620971369,1.7709929999,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,526,125,29377.153851,8201.5486952,105226.12258,0,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2063,707,1.5322602893,0.4936661361,4.7558895022,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2262,1414,0.9530120291,0.658368449,1.3795192175,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,526,631,1.9855517523,0.3047032632,12.938541322,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2063,2611,1.1152143544,0.5586934283,2.2260921519,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2262,4195,1.3266668087,0.9782476373,1.7991812648,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,526,125,494187.06035,156699.73834,1558527.4947,0,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2062,708,1.7020540105,0.2092557443,13.844245299,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2263,1421,0.7350654237,0.4535716623,1.1912586743,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,487801.34135,157278.13051,1512925.8458,0,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2062,2612,1.4733769173,0.4682522218,4.6360474967,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2263,4201,1.0273628716,0.6942009187,1.5204164117,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,MPCD,526,125,755786.82872,232437.10932,2457497.9965,0,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2062,708,3.1460610453,0.3511111087,28.189652382,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Medicare,2263,1421,0.8662922037,0.4996536775,1.5019646929,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,747783.02044,233706.32768,2392658.5609,0,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2062,2612,2.2470709955,0.598075008,8.442633434,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2263,4201,1.2943398839,0.8047286618,2.0818392764,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,526,125,774202.37057,237737.40174,2521224.2845,0,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2062,708,3.2474821654,0.3621269727,29.122769663,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2263,1421,0.8530411515,0.4936605394,1.4740477475,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,526,631,748655.82489,234293.84919,2392233.2835,0,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2062,2612,2.2543259066,0.5998968919,8.4714312771,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2263,4201,1.3135237843,0.8142604125,2.1189102471,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,526,125,759154.27394,232266.52872,2481266.7362,0,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2062,708,2.9606583441,0.3324719409,26.364624359,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2263,1421,0.8285730263,0.4726640659,1.4524761018,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,526,631,739975.88885,230185.00137,2378801.0202,0,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2062,2612,2.2512896718,0.5999360801,8.44807531,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2263,4201,1.3138819541,0.8199573842,2.1053359878,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,526,125,753085.78908,231569.20953,2449108.8727,0,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2062,708,3.1523372079,0.3517823861,28.248230338,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2263,1421,0.8653348463,0.4994505476,1.4992563326,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,526,631,749370.44095,234196.02049,2397803.5861,0,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2062,2612,2.2404797632,0.5964377047,8.4162177038,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2263,4201,1.2990457858,0.8061091923,2.093413609,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,526,125,775566.68273,236799.93438,2540134.485,0,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2062,708,3.0830725353,0.3457429999,27.492490837,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2263,1421,0.8149123958,0.4666377193,1.4231215894,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,526,631,743930.93435,231770.71577,2387847.9783,0,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2062,2612,2.2584117834,0.6015513019,8.4787843817,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2263,4201,1.336660027,0.8301789739,2.1521383749,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,526,125,4.3699371695,0.6007134836,31.789449357,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2065,708,0.9586896029,0.6759866086,1.3596212454,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2271,1423,0.8634055652,0.7455478886,0.9998944151,1,1
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,2.828943019,1.2934382991,6.1873215062,1,1
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2065,2615,2.0814818163,1.5938702974,2.7182679537,1,1
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2271,4212,1.2611787075,1.1242349228,1.4148037034,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,526,125,5.0630907646,0.677088547,37.860466261,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2065,708,0.9947845882,0.683674258,1.4474676577,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,2271,1423,0.8774585379,0.7414189891,1.0384593556,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,3.5471860464,1.5160184194,8.299720298,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2065,2615,2.3263028674,1.7240395488,3.138956432,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2271,4212,1.3522655111,1.1722148751,1.5599716838,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,526,125,5.0969280914,0.6813350604,38.129075512,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2065,708,0.9848177429,0.6765106085,1.4336301229,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2271,1423,0.8801938914,0.743909711,1.0414453193,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,526,631,3.5598413394,1.5214332461,8.3292976501,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2065,2615,2.3305996758,1.7267483247,3.1456204537,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2271,4212,1.350547042,1.1704671272,1.5583327974,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,526,125,5.0597686644,0.6782062529,37.74848555,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2065,708,1.0192906161,0.6991933896,1.4859313252,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2271,1423,0.8923667302,0.7516577449,1.0594161857,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,526,631,3.5629500735,1.5224638479,8.3382033954,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2065,2615,2.3234549818,1.7214404362,3.136003395,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2271,4212,1.3451263216,1.166798478,1.5507089315,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,526,125,5.0807785516,0.6793587861,37.998052306,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2065,708,0.9927891163,0.6822090986,1.4447626561,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2271,1423,0.8787544066,0.7417465138,1.0410690078,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,526,631,3.5445058505,1.5148190758,8.2937440683,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2065,2615,2.3316304638,1.7287531052,3.1447524828,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2271,4212,1.3485541513,1.1706674237,1.5534713465,1,1
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,526,125,5.1022645861,0.6834449225,38.091004923,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2065,708,1.0068039943,0.6902776439,1.4684732904,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2271,1423,0.895563671,0.7543705672,1.0631834321,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,526,631,3.5718370204,1.5261262117,8.3597408934,1,1
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2065,2615,2.3317346411,1.7277738917,3.1468159478,1,1
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2271,4212,1.3404241387,1.1642130447,1.5433059094,1,1
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,526,125,0.7585948898,0.1612552078,3.5686674229,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2065,708,0.7036617901,0.3995775501,1.239158493,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2271,1423,0.9104650373,0.6884062722,1.2041531545,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,4.6010917511,0.9778816879,21.648882032,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2065,2615,2.2407218377,1.3495915888,3.7202620376,1,1
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2271,4212,1.3551394787,1.0844307371,1.6934258169,1,1
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,526,125,0.6466429442,0.1203786003,3.4735999281,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2065,708,0.6566576487,0.3493017307,1.2344607245,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,2271,1423,0.9620980416,0.6951054375,1.3316435057,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,4.011254611,0.8227705512,19.556076151,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2065,2615,2.2121524255,1.2410195176,3.943224328,1,1
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2271,4212,1.5910021239,1.206303432,2.0983839483,1,1
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,526,125,0.6510206104,0.120968372,3.5036251879,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2065,708,0.6638717947,0.3525835362,1.2499896181,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2271,1423,0.9541781643,0.6902679276,1.3189892399,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,526,631,4.023873227,0.8241550168,19.646250302,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2065,2615,2.2119793141,1.2409555162,3.9428105376,1,1
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2271,4212,1.6002978179,1.2114495017,2.1139577857,1,1
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,526,125,0.6506985516,0.12080418,3.5049168409,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2065,708,0.6904916033,0.3677133747,1.2966040593,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2271,1423,0.9973775455,0.7192329374,1.3830873372,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,526,631,4.0602866926,0.8326905911,19.79838394,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2065,2615,2.2077258377,1.2387818773,3.9345533411,1,1
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2271,4212,1.5701475957,1.1896499419,2.0723436243,1,1
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,526,125,0.6463469796,0.1201649839,3.4765903049,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2065,708,0.6567965359,0.3493203579,1.2349171178,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2271,1423,0.9620261976,0.6951464952,1.3313659945,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,526,631,4.0113850796,0.8228446449,19.555587261,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2065,2615,2.2115583961,1.2407679054,3.9419060714,1,1
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2271,4212,1.5915944251,1.2056667394,2.1010555663,1,1
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,526,125,0.6545326048,0.1211776188,3.5354130166,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2065,708,0.6974013045,0.3708576652,1.311469669,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2271,1423,0.9900810297,0.7147624943,1.3714491921,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,526,631,4.0749804567,0.8343830184,19.901490511,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2065,2615,2.2032429236,1.2363310126,3.9263589858,1,1
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2271,4212,1.5830399822,1.1963756675,2.0946728131,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,524,125,1.3218100015,0.4609264207,3.7905869604,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2022,705,1.3385791826,0.8049432261,2.2259883306,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2238,1403,1.5171101728,1.0752258358,2.1405952125,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,524,626,3.6962611499,1.6660925486,8.2002326342,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2022,2576,5.1432771394,3.1611834957,8.368163306,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2238,4172,3.0978022596,2.3281841615,4.1218297928,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,524,125,1.3416539059,0.4432930457,4.0605987864,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2022,705,1.295955435,0.7056431897,2.3800987722,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,2238,1403,1.6824719689,1.1341173161,2.4959604144,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,524,626,3.4706027134,1.494168722,8.0613942834,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2022,2576,4.2354723339,2.2726794468,7.8934254966,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2238,4172,3.3870195091,2.3929918372,4.7939574957,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,524,125,1.353037211,0.4475453905,4.0905564732,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2022,705,1.3052718469,0.7103565929,2.3984215973,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2238,1403,1.6713603502,1.1281410464,2.4761490853,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,524,626,3.4860406841,1.5013986444,8.0941059165,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2022,2576,4.2306095338,2.2692849338,7.8870911099,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2238,4172,3.4128015388,2.4066209502,4.8396546793,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,524,125,1.3416754113,0.4432384828,4.0612288401,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2022,705,1.2895268177,0.6984579171,2.3807868349,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2238,1403,1.6766539029,1.1253219437,2.4981013885,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,524,626,3.4681437357,1.4932171205,8.0551051861,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2022,2576,4.2380848778,2.274771595,7.895897536,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2238,4172,3.3917530406,2.3996014821,4.7941246805,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,524,125,1.3556377216,0.4476354754,4.1054691442,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2022,705,1.2874368161,0.7007928583,2.3651690163,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2238,1403,1.6944779995,1.1374655977,2.52425717,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,524,626,3.4629639881,1.4907388922,8.0444131734,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2022,2576,4.2576610662,2.2872750752,7.9254471623,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2238,4172,3.369046865,2.3869865613,4.7551490079,1,1
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,524,125,1.3659858305,0.451407846,4.1335508585,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2022,705,1.2900363563,0.6986043428,2.3821692744,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2238,1403,1.6751382509,1.1229920359,2.4987605167,1,1
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,524,626,3.4725772669,1.4955803951,8.0629519579,1,1
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2022,2576,4.2641099278,2.2915061322,7.9347959059,1,1
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2238,4172,3.3992307403,2.4078337483,4.798823687,1,1
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,523,125,111547.05358,61057.070324,203788.76837,0,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2044,706,1.121431492,0.5735723881,2.1925891433,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2255,1410,1.1296546076,0.7570741716,1.6855938034,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,523,628,3.4811635071,1.1212268666,10.808249181,1,1
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2044,2598,3.1848110627,1.8597872307,5.4538612471,1,1
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2255,4188,2.4866874362,1.7655242702,3.5024239029,1,1
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,523,125,71368.82437,38405.065384,132625.9711,0,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2044,706,0.9091285049,0.4133542398,1.9995310532,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,2255,1410,1.390872899,0.7928025753,2.4401124333,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,523,628,3.0375196547,0.955014547,9.6611362425,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2044,2598,3.5530988966,2.0134989348,6.2699371484,1,1
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2255,4188,3.2681970641,1.9235241747,5.5528868261,1,1
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,523,125,195877.7611,105152.59104,364880.18903,0,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2044,706,0.9217024833,0.4182951725,2.0309473394,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2255,1410,1.3845785131,0.793249019,2.416716079,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,523,628,3.0393581184,0.9557353199,9.665539799,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2044,2598,3.5468667646,2.0102817838,6.2579604251,1,1
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2255,4188,3.2878466943,1.9271094504,5.609404221,1,1
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,523,125,71461.104388,38454.621928,132797.80646,0,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2044,706,0.9374461171,0.4245685046,2.0698785072,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2255,1410,1.4223261772,0.7895171265,2.562340558,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,523,628,3.0624031066,0.9621436535,9.7473103456,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2044,2598,3.5433279524,2.0079825051,6.252630661,1,1
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2255,4188,3.2431945116,1.9282432069,5.4548672087,1,1
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,523,125,71032.528591,38203.454199,132072.35377,0,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2044,706,0.9166285392,0.4167338429,2.0161738555,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2255,1410,1.385886715,0.7905254021,2.4296271591,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,523,628,3.0436437967,0.9569405207,9.680609569,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2044,2598,3.5318493374,2.0017588367,6.2314997759,1,1
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2255,4188,3.2993205989,1.94105017,5.6080551559,1,1
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,523,125,194837.34969,104512.32926,363225.97632,0,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2044,706,0.9592810319,0.4336890199,2.1218432007,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2255,1410,1.4224182609,0.7888210702,2.5649336526,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,523,628,3.0634559343,0.9626274969,9.7491109408,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2044,2598,3.5115077371,1.9902126569,6.1956628326,1,1
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2255,4188,3.3066311959,1.9469045889,5.6159967612,1,1
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,526,125,823775.54321,114499.64682,5926709.5089,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2064,708,390427.37156,95581.994471,1594793.3845,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2271,1423,1.1581378453,0.4042874893,3.3176472293,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,1.145973681,0.0717389452,18.306035509,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2064,2614,1.0718464855,0.1482280326,7.7505912228,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2271,4212,3.2428973425,1.2085942079,8.701335076,1,1
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,MPCD,526,125,1116866.3048,153583.92264,8121880.9977,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2064,708,178825.38057,42834.970191,746551.62813,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Medicare,2271,1423,0.9489143627,0.3123181169,2.8830811251,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,2.130429925,0.1327067609,34.201208996,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2064,2614,0.6196099812,0.0844633042,4.5453647887,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2271,4212,2.6405868107,0.9260294271,7.5296729247,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,526,125,2893959.3959,388233.29939,21572083.071,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2064,708,495801.78225,117553.96924,2091119.5842,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2271,1423,0.9746917057,0.3139041591,3.0264776482,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,526,631,2.0925346031,0.1297899898,33.736816459,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2064,2614,0.6146116298,0.0837373188,4.5111004378,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2271,4212,2.6272988367,0.9295765491,7.4256382473,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,526,125,1114471.7501,153158.75089,8109541.7305,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2064,708,187935.43824,44784.01255,788668.25316,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2271,1423,0.9831072682,0.3100590176,3.1171481746,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,526,631,2.1513586819,0.1348225765,34.329147963,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2064,2614,0.6186172012,0.0843796215,4.5353040793,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2271,4212,2.608630731,0.9315324884,7.3051175082,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,526,125,3028241.8347,416271.6039,22029483.932,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2064,708,500191.466,119880.40626,2087009.1324,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2271,1423,0.9407001667,0.3095034376,2.8591501617,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,526,631,2.1374926937,0.1331685699,34.308959077,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2064,2614,0.612954257,0.0835012904,4.4994864055,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2271,4212,2.6735157847,0.9369890627,7.6283565472,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,526,125,2880639.5485,388993.37662,21332199.228,0,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2064,708,538206.60933,127543.75056,2271113.6615,0,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2271,1423,1.015861311,0.3103663849,3.3250192465,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,526,631,2.113809764,0.1320707623,33.831800767,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2064,2614,0.6102878781,0.0831606504,4.4786962634,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2271,4212,2.6333874209,0.9435294177,7.3497754058,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,526,125,1352009.9562,328598.92074,5562802.5727,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2065,708,0.2676090348,0.0167734461,4.2695219025,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2271,1423,0.913468946,0.3310277751,2.5207114871,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,1348096.3798,332382.95315,5467680.674,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2065,2615,1.1378075263,0.0711277927,18.201126698,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2271,4212,2.1148255802,0.8664535389,5.161831574,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,MPCD,526,125,892085.07498,206467.35176,3854438.8457,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2065,708,0.4839805502,0.0306036961,7.6538850773,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Medicare,2271,1423,0.6364319412,0.2239781633,1.8084156497,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,890509.96333,208842.93701,3797150.1748,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2065,2615,2.6186292258,0.1648365243,41.60011898,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2271,4212,1.4618614302,0.5745384201,3.7195751687,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,526,125,2508027.1089,578872.63929,10866293.467,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2065,708,0.4936370411,0.0311089146,7.8330450095,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2271,1423,0.6325038669,0.2252752321,1.7758771701,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,526,631,2465779.0697,577839.7072,10522064.068,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2065,2615,2.6309422074,0.1656085545,41.796493667,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2271,4212,1.4743172157,0.5734119591,3.7906625738,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,526,125,904184.95866,208505.53603,3921001.1159,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2065,708,0.4181413808,0.0270430806,6.4653216489,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2271,1423,0.5749608082,0.197946183,1.6700495353,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,526,631,874100.09959,204696.48309,3732604.3544,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2065,2615,2.6459762767,0.1665234776,42.043263567,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2271,4212,1.5135439513,0.5974786929,3.8341372167,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,526,125,888621.95642,205627.77709,3840186.3435,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2065,708,0.4854803257,0.0306894952,7.679863913,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2271,1423,0.6334348276,0.2230338804,1.7990077564,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,526,631,899286.715,210910.14495,3834412.9723,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2065,2615,2.6064113911,0.1640692981,41.405554971,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2271,4212,1.4717272295,0.5769228879,3.7543683624,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,526,125,2483844.26,570484.78514,10814455.474,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2065,708,0.4323150463,0.0277366313,6.7382479512,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2271,1423,0.5629024302,0.1954496377,1.6211805237,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,526,631,2429010.5432,568026.8571,10386995.166,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2065,2615,2.6499044361,0.166666253,42.132065695,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2271,4212,1.5257449618,0.5946320886,3.9148537943,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,526,125,1.0116912978,0.8044179603,1.2723724887,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2064,708,0.505121787,0.0458012717,5.5707627838,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2270,1423,0.5666056734,0.2925386837,1.0974343125,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,0.9974913452,0.8759456016,1.1359027113,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2064,2615,815637.56522,204097.75101,3259539.2869,0,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2270,4211,2.3457418369,1.1693639339,4.7055536822,1,1
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,526,125,1.0201685477,0.7893316966,1.3185126991,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2064,708,0.7669215139,0.0664067304,8.8570632067,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,2270,1423,0.5724838644,0.2767518294,1.1842298415,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,1.0055491233,0.8627768697,1.1719473192,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2064,2615,703504.79201,162698.44149,3041940.5856,0,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2270,4211,2.4397653191,1.1376653153,5.2321669057,1,1
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,526,125,0.9434738639,0.7029332351,1.2663264268,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2064,708,0.7296053576,0.062682424,8.492396175,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2270,1423,0.5787590086,0.2756633748,1.2151124185,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,526,631,0.9868173788,0.8342959454,1.1672219486,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2064,2615,675102.84515,156095.33774,2919778.7592,0,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2270,4211,2.3949314934,1.1284581411,5.0827732539,1,1
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,526,125,1.0179804673,0.7876624584,1.315645072,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2064,708,0.8073452143,0.0703685578,9.2627490887,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2270,1423,0.5948424192,0.2823077109,1.2533752709,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,526,631,1.0161592119,0.8721139969,1.1839960688,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2064,2615,700773.77535,161831.29995,3034542.047,0,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2270,4211,2.4074078396,1.1278425596,5.1386715789,1,1
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,526,125,1.0246168615,0.792078809,1.3254233049,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2064,708,0.7645505958,0.0662745882,8.8199358075,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2270,1423,0.5742912193,0.2778063073,1.1871955242,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,526,631,1.0047394749,0.8618665127,1.171296712,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2064,2615,709436.75663,163591.62168,3076566.5532,0,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2270,4211,2.4279799108,1.129493667,5.2192293054,1,1
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,526,125,0.992473175,0.7460620927,1.3202694692,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2064,708,0.7647296846,0.0663998081,8.8074274129,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2270,1423,0.6027418259,0.2820904862,1.2878765023,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,526,631,1.0181241359,0.8560439472,1.2108919869,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2064,2615,676812.7663,156122.10095,2934085.0387,0,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2270,4211,2.3529635325,1.1097477062,4.9889153676,1,1
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,525,125,38568.325598,15688.398932,94816.287234,0,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2055,708,0.7893349604,0.3164365411,1.9689561692,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2263,1408,1.0025286008,0.7297579739,1.3772560649,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,525,630,0.8185295126,0.2601969997,2.5749357747,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2055,2600,2.0510206489,0.9553593935,4.403249427,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2263,4194,1.4036017723,1.0967875538,1.7962438837,1,1
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,MPCD,525,125,27660.171315,10809.82649,70776.813845,0,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2055,708,0.7719923147,0.2923046579,2.0388732029,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,Medicare,2263,1408,0.9968447797,0.7082757364,1.4029839847,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,525,630,0.6282407757,0.1925063434,2.0502517753,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2055,2600,2.2444903771,0.9904810415,5.0861519219,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2263,4194,1.4758049541,1.1181493815,1.9478616172,1,1
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,525,125,27234.23888,10626.657312,69796.526379,0,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2055,708,0.7751376761,0.2926051464,2.0534102846,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2263,1408,1.0022196616,0.7119951568,1.4107459025,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,525,630,0.6231263589,0.1908561893,2.0344452054,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2055,2600,2.2433149495,0.9898120348,5.0842602291,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2263,4194,1.4763077058,1.1177924855,1.9498113206,1,1
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,525,125,27675.433802,10813.710142,70829.49571,0,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2055,708,0.7657707198,0.2894440099,2.0259697054,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2263,1408,0.9913872002,0.7020346668,1.4000000673,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,525,630,0.627475129,0.1923215438,2.0472227388,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2055,2600,2.2451582938,0.9907539732,5.0877774916,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2263,4194,1.4787727374,1.121660717,1.9495813446,1,1
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,525,125,27551.95061,10765.238289,70514.9261,0,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2055,708,0.7746457287,0.2932898055,2.0460172622,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2263,1408,0.9955623364,0.7077447601,1.4004262859,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,525,630,0.6291086093,0.1927710529,2.0530968542,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2055,2600,2.2389552967,0.98806932,5.0734505352,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2263,4194,1.4819930495,1.1227987738,1.9560970763,1,1
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,525,125,27141.026242,10586.883311,69579.996664,0,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2055,708,0.7720026058,0.2908672714,2.0490033839,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2263,1408,0.9966156017,0.7055237232,1.4078090145,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,525,630,0.6230332659,0.1908773542,2.0336118548,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2055,2600,2.2381092458,0.9875061133,5.072508341,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2263,4194,1.4842034199,1.1247074956,1.9586068379,1,1
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,526,125,1.0185430949,0.8135081171,1.2752546832,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2065,708,4055450.0261,587226.30862,28007387.736,0,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2271,1423,2.8022897183,0.3213676113,24.435653718,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,1.0033510784,0.8832234641,1.1398173027,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2065,2613,4048284.3725,583509.03482,28086294.099,0,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2271,4212,2.4343215296,0.6537871868,9.0639912028,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,MPCD,526,125,1.0370711408,0.8000117879,1.3443758798,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2065,708,1139849.9187,162179.84352,8011216.4917,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,Medicare,2271,1423,3.9561754259,0.4423240066,35.384296959,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,631,1.0148180484,0.8744459743,1.1777236119,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2065,2613,1135707.6284,161297.43327,7996604.7264,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2271,4212,2.8360593732,0.6905630494,11.647354684,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,526,125,0.9952809515,0.7841685589,1.2632286275,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2065,708,1172802.6407,166583.72712,8256905.1473,0,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2271,1423,4.0788736299,0.4466893763,37.245591611,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,526,631,1.0151753547,0.8620626797,1.1954826779,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2065,2613,1139015.1347,161704.1997,8023016.5919,0,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2271,4212,2.8128284642,0.6971645194,11.34883338,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,526,125,1.0642821027,0.8032947681,1.4100632037,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2065,708,1280662.047,179371.35529,9143574.1007,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2271,1423,4.2965622994,0.4645764592,39.736080524,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,526,631,1.0450166426,0.8823720051,1.2376410143,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2065,2613,1117031.6615,158691.13265,7862819.5029,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2271,4212,2.7380956642,0.6774097555,11.067404632,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,526,125,1.0097799024,0.7762397125,1.3135832075,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2065,708,1178404.1953,167614.46654,8284705.2303,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2271,1423,3.9325369314,0.4396197171,35.177782334,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,526,631,1.0178186608,0.8764402987,1.1820027306,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2065,2613,1144082.4291,162483.30394,8055748.3314,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2271,4212,2.872230928,0.6993173914,11.796804435,1,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,526,125,0.9982120517,0.7721893503,1.2903924403,1,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2065,708,1364913.1433,189925.97175,9809021.2278,0,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2271,1423,4.5571715884,0.4762975224,43.602605327,1,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,526,631,1.0413623491,0.8730357226,1.2421433786,1,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2065,2613,1134392.3681,160820.81783,8001737.9729,0,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2271,4212,2.789007283,0.6999602294,11.112862272,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,524,125,49678.952353,6848.6111497,360364.78826,0,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2063,707,2.0229404994,0.2535272961,16.141410913,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2269,1422,1.0479896077,0.3960989193,2.7727473225,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,524,631,1.1655731886,0.0725946621,18.714335454,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2063,2614,0.9619214769,0.3727729562,2.4821889904,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2269,4203,1.1721557363,0.569823367,2.4111841486,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,MPCD,524,125,26210.871137,3596.6760744,191012.41022,0,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2063,707,1.813769328,0.2219402421,14.822725002,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Medicare,2269,1422,1.1622632279,0.3768034928,3.5850405756,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,524,631,0.6371611681,0.0396187284,10.247031402,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2063,2614,0.7954335423,0.2840643846,2.2273630712,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2269,4203,1.3445575328,0.5393932086,3.3516086783,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,524,125,154540.28431,21096.282046,1132080.9716,0,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2063,707,1.7737596025,0.2175158282,14.464341072,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2269,1422,1.1957035287,0.3875141207,3.6894318221,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,524,631,0.6337552796,0.0393929563,10.195877442,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2063,2614,0.7968030864,0.2844726857,2.2318317023,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2269,4203,1.3284273127,0.5320832537,3.3166221879,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,524,125,26205.093994,3594.6662899,191034.96566,0,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2063,707,1.8190998381,0.2187366982,15.128344937,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2269,1422,1.164854819,0.380357414,3.5673992395,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,524,631,0.6375560611,0.0397150363,10.234857342,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2063,2614,0.7953303413,0.2842350354,2.2254482132,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2269,4203,1.3437069578,0.5370169165,3.3621815868,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,524,125,26290.176363,3607.4133748,191598.0514,0,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2063,707,1.8117946403,0.2218205706,14.798446378,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2269,1422,1.1634792741,0.3782649348,3.5786664231,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,524,631,0.6369189911,0.0396031559,10.243269548,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2063,2614,0.7966843561,0.2839971325,2.2349027179,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2269,4203,1.3416854992,0.5341684539,3.3699481234,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,524,125,155357.61689,21191.554737,1138943.7643,0,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2063,707,1.7766645052,0.2139029812,14.756861952,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2269,1422,1.1998490099,0.3923496338,3.6692723083,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,524,631,0.6341659622,0.0394921591,10.183451024,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2063,2614,0.7974965762,0.2845015997,2.2354910823,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2269,4203,1.3261890742,0.5270624156,3.3369434217,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,524,124,40096.53163,16190.878924,99298.61475,0,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2059,706,3.2333809694,0.4236774513,24.676207007,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2229,1389,1.0005020461,0.7118686445,1.4061643984,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,524,630,0.8145051936,0.2575600164,2.5757829943,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2059,2612,0.6630508214,0.3324727239,1.3223231868,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2229,4139,0.9022504936,0.7059308365,1.1531667286,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,524,124,46345.431246,16981.730499,126482.92808,0,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2059,706,4.7942549521,0.611070153,37.6141437,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,2229,1389,1.0718840412,0.7015398932,1.6377335186,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,524,630,0.7937119823,0.221569573,2.8432546142,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2059,2612,0.8572369675,0.3942208404,1.8640699406,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2229,4139,0.9399824312,0.6605573236,1.3376083186,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,524,124,26556.650803,9885.185833,71344.708515,0,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2059,706,4.7579232024,0.6060472869,37.353245679,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2229,1389,1.0616589181,0.6967785967,1.6176152136,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,524,630,0.8169006722,0.2281419537,2.9250503789,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2059,2612,0.8509321554,0.391107446,1.8513724058,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2229,4139,0.9464474084,0.6630407047,1.3509920139,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,524,124,46366.908906,16984.372679,126580.4915,0,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2059,706,4.7720357889,0.6080166453,37.453457476,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2229,1389,1.0684373402,0.6857829405,1.6646059307,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,524,630,0.7928960682,0.2213545971,2.8401676911,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2059,2612,0.8573924111,0.3943296888,1.8642312956,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2229,4139,0.9413096202,0.6675326798,1.3273714201,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,524,124,47243.57811,17299.158386,129021.05541,0,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2059,706,4.7678139928,0.6076218148,37.411511105,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2229,1389,1.0762636413,0.7051033369,1.6427995231,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,524,630,0.7920287422,0.2210931247,2.8373090718,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2059,2612,0.8638016954,0.3970487928,1.8792485521,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2229,4139,0.9299147974,0.672512854,1.2858364346,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,524,124,26923.556705,10008.347234,72427.333779,0,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2059,706,4.701714057,0.5988386362,36.914977989,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2229,1389,1.060768179,0.6874373927,1.6368459753,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,524,630,0.8083376166,0.2259820798,2.8914226428,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2059,2612,0.859925733,0.3950591695,1.8718012983,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2229,4139,0.9383078689,0.681128337,1.2925929067,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,522,124,0.7806554042,0.1666490852,3.6569229252,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2054,703,1.1939105371,0.5295736426,2.6916414564,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2204,1364,0.626049732,0.4692882317,0.8351759972,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,522,624,0.4705598079,0.2064394093,1.0725981708,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2054,2603,1.3408062108,0.8098453774,2.2198821469,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2204,4101,0.7514128286,0.5971798889,0.9454793262,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,522,124,0.8227687299,0.1494320552,4.5301416892,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2054,703,1.2766528884,0.5434255309,2.9992013714,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,2204,1364,0.7001839114,0.4800119425,1.0213444009,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,522,624,0.7574762559,0.2549092279,2.2508807667,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2054,2603,0.9405794265,0.4554545077,1.9424325428,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2204,4101,0.8669622276,0.6221945096,1.2080201487,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,522,124,0.8329036261,0.151688158,4.5733856859,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2054,703,1.2692329019,0.5396052,2.9854274186,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2204,1364,0.6986634308,0.4803337489,1.0162321316,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,522,624,0.7599095836,0.2552121134,2.2626769848,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2054,2603,0.9420936747,0.4558380655,1.9470521641,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2204,4101,0.8651442267,0.6187550798,1.2096458799,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,522,124,0.8217874791,0.1488685953,4.5364481314,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2054,703,1.3584517051,0.5777800328,3.1939335563,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2204,1364,0.7337587181,0.4965431166,1.0843003124,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,522,624,0.766870383,0.2568944488,2.2892288532,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2054,2603,0.937431423,0.4545271366,1.9333887949,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2204,4101,0.8503010879,0.6148347918,1.1759450665,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,522,124,0.8316499678,0.1509829721,4.5809249824,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2054,703,1.2699141256,0.5401819126,2.9854422163,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2204,1364,0.7025924575,0.4808108177,1.0266744076,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,522,624,0.7566226855,0.2545859601,2.2486624479,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2054,2603,0.9470891343,0.4588647446,1.9547760837,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2204,4101,0.8598709314,0.628209814,1.176960312,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,522,124,0.8363425946,0.1518077137,4.6075981153,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2054,703,1.340316646,0.5691064407,3.1566128634,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2204,1364,0.7311673941,0.5006277788,1.0678707432,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,522,624,0.7664645552,0.2561101461,2.29380961,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2054,2603,0.942941374,0.4572239947,1.9446451743,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2204,4101,0.8408087223,0.618797362,1.1424730467,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,524,123,109415.94203,65883.445094,181712.5433,0,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2032,702,0.9019148443,0.5552866296,1.4649198145,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2254,1407,1.3762642351,0.990494522,1.912280384,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,524,629,10.64422285,2.4677496766,45.912063591,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2032,2597,3.0443424556,1.9580568553,4.7332747065,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2254,4175,2.3138302758,1.7819581183,3.0044536345,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,MPCD,524,123,117485.54851,61885.536381,223038.44994,0,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2032,702,0.7950483354,0.4656867805,1.3573540886,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Medicare,2254,1407,1.2541732207,0.8731120237,1.8015448474,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,524,629,14.259885347,3.0493154553,66.685239063,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2032,2597,2.716474875,1.6565666321,4.4545360286,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2254,4175,2.1062929659,1.5543219647,2.8542799749,1,1
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,524,123,120055.80827,62051.263773,232282.08781,0,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2032,702,0.8006085787,0.4691204264,1.3663316716,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2254,1407,1.2490390353,0.8704745773,1.7922390295,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,524,629,14.340357751,3.0581345188,67.245524731,1,1
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2032,2597,2.7217247648,1.6594356244,4.4640392112,1,1
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2254,4175,2.120336042,1.5607835073,2.8804923362,1,1
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,524,123,117510.95159,61880.472909,223153.17086,0,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2032,702,0.7875257754,0.4606699635,1.3462932162,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2254,1407,1.2459246806,0.8681268066,1.7881354407,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,524,629,14.230754136,3.0439571389,66.529965446,1,1
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2032,2597,2.7185283804,1.6575814814,4.4585419406,1,1
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2254,4175,2.1123353615,1.5575409174,2.8647470058,1,1
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,524,123,117073.83944,61658.574726,222293.23239,0,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2032,702,0.7974132243,0.4670019775,1.3615956267,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2254,1407,1.2510787186,0.8711422788,1.7967190874,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,524,629,14.272564127,3.0520217295,66.744638413,1,1
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2032,2597,2.7093651813,1.6519612968,4.4436027042,1,1
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2254,4175,2.1140458464,1.5606277205,2.8637129677,1,1
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,524,123,119542.01867,61711.461457,231566.29077,0,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2032,702,0.7964756735,0.465991927,1.3613401042,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2254,1407,1.23774654,0.8635308012,1.7741306914,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,524,629,14.325373818,3.0555399909,67.162051757,1,1
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2032,2597,2.7164748009,1.6556321119,4.4570501449,1,1
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2254,4175,2.1332246325,1.5695094041,2.8994074969,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,523,123,2.3105542224,0.7111101533,7.5075018822,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2012,703,0.8839521489,0.5899661966,1.3244341898,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2240,1398,1.3662141505,1.0122714785,1.8439135593,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,523,626,13.193026988,4.0497718641,42.979201533,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2012,2577,4.9259412982,3.1509367464,7.7008520406,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2240,4174,3.722036887,2.8421069052,4.8743974278,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,MPCD,523,123,3.2120352382,0.9690873648,10.646274781,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2012,703,0.9170113251,0.5827393803,1.4430289057,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Medicare,2240,1398,1.1996106689,0.8686402469,1.656687866,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,523,626,15.374020218,4.5870639823,51.527621713,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2012,2577,5.2632890487,3.2423954077,8.5437487186,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2240,4174,3.2943470028,2.4466654991,4.435719627,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,523,123,3.2356930939,0.9763984426,10.722784205,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2012,703,0.9263523224,0.5888358225,1.4573308761,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2240,1398,1.1976479624,0.8668912368,1.65460277,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,523,626,15.352826086,4.5775545317,51.492399969,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2012,2577,5.2747474204,3.249897747,8.5611802323,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2240,4174,3.3086442934,2.457052615,4.45538976,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,523,123,3.2125099951,0.9693474841,10.646564455,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2012,703,0.9211836479,0.5864619148,1.4469470084,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2240,1398,1.2033483665,0.8694974103,1.6653842484,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,523,626,15.391243202,4.5905693401,51.603700925,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2012,2577,5.2605223651,3.2396504425,8.5420004551,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2240,4174,3.2896863572,2.4446349998,4.4268515872,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,523,123,3.1938712103,0.9635765206,10.586407088,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2012,703,0.9189265817,0.5839917841,1.4459553807,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2240,1398,1.1962773783,0.8667145961,1.6511543387,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,523,626,15.395789083,4.5936298271,51.599787188,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2012,2577,5.2441421921,3.2305669531,8.5127557269,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2240,4174,3.3101521715,2.4589527558,4.4560056605,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,523,123,3.2168638564,0.9707967767,10.659504975,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,2012,703,0.9328752788,0.5942701962,1.4644117966,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2240,1398,1.1999633085,0.8667622929,1.6612535566,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,523,626,15.377788954,4.5837177071,51.59052285,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,2012,2577,5.2515489617,3.2344970156,8.5264467284,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2240,4174,3.3203731981,2.4674569005,4.4681137783,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,515,122,0.5859432657,0.2609551457,1.3156648424,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,1999,689,1.258636513,0.830424764,1.9076573103,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2215,1351,1.3752996953,1.0442834853,1.8112411798,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,515,615,1.5017013031,0.8119320877,2.7774574228,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1999,2552,1.6517870054,1.2588159409,2.1674338738,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2215,4133,1.9636176996,1.5967137627,2.4148313619,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,515,122,0.6462408705,0.2801434279,1.4907623065,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,1999,689,1.180712267,0.7352279095,1.8961215147,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,2215,1351,1.1342639486,0.8421479608,1.5277062523,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,515,615,1.5591552435,0.8220764023,2.9571035816,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,1999,2552,1.8003464615,1.3099575353,2.4743148494,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2215,4133,1.632614515,1.2896714463,2.0667513127,1,1
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,515,122,0.6439946631,0.2796872982,1.4828314652,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,1999,689,1.1692834359,0.7283090346,1.8772577142,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2215,1351,1.1304066256,0.8395036172,1.5221127258,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,515,615,1.5790222797,0.8313758963,2.9990180987,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,1999,2552,1.8038297907,1.3131622104,2.4778370015,1,1
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2215,4133,1.627909605,1.2855184032,2.061494939,1,1
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,515,122,0.6493532881,0.2813738339,1.498574643,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,1999,689,1.1454376637,0.7116327268,1.843686205,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2215,1351,1.1098155021,0.8232208579,1.4961846956,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,515,615,1.5546415363,0.8193041819,2.9499548028,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,1999,2552,1.8021408603,1.3112370076,2.4768303986,1,1
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2215,4133,1.6490944325,1.3036866273,2.0860169846,1,1
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,515,122,0.6432095255,0.27881148,1.4838646301,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,1999,689,1.1825094293,0.7363751693,1.8989349568,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2215,1351,1.1342083527,0.8422895161,1.5272997738,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,515,615,1.560629829,0.8228593172,2.9598807622,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,1999,2552,1.7948390509,1.306054855,2.4665481747,1,1
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2215,4133,1.6408124923,1.2959982247,2.0773683047,1,1
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,515,122,0.6451562489,0.2801206659,1.4858831789,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,1999,689,1.1372559643,0.7066256447,1.8303201107,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,2215,1351,1.1054636327,0.8203376385,1.4896913002,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,515,615,1.5731492502,0.8280668064,2.9886460179,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,1999,2552,1.7983178022,1.3093312341,2.4699226852,1,1
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,2215,4133,1.6498419587,1.3036392085,2.0879845212,1,1
